Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients

Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients

Abstract Lung squamous cell carcinoma (LUSC) is a common type of lung cancer with high incidence and mortality rate. Tumor mutational burden (TMB) is an emerging biomarker for selecting patients with non-small cell lung cancer (NSCLC) for immunotherapy. This study aimed to reveal TMB involved in the...

Full description

Saved in:
Bibliographic Details
Main Authors: Dan Yan, Yi Chen
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/d01fd21c42fb47f7bb59d61136ca06e3
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items